CREATES Act Advances in Senate
The Senate Judiciary Committee today voted 16-5 to approve the Creating and Restoring Equal Access to Equivalent Samples Act (S. 974). The AHA-supported bill would allow generic drug manufacturers facing certain anticompetitive delay tactics to bring an action in federal court for injunctive relief. More than 45 organizations, including the AHA, last week urged the committee to support the legislation to “end the anticompetitive abuses utilized by some brand-name manufacturers, help restore the balance between innovation and affordability that Congress intended, and achieve the goal of more affordable prescription drugs.” The Congressional Budget Office estimates the legislation will save $3.8 billion over 10 years.
Related News Articles
Headline
The House Energy and Commerce Committee Sept. 18 advanced legislation on expiring telehealth and hospital-at-home flexibilities. The AHA supported the passage…
Headline
The Coalition to Strengthen America’s Healthcare Sept. 18 sponsored an event with Politico in Washington, D.C. to discuss innovations in telehealth, artificial…
Headline
Sens. Chuck Schumer, D-N.Y., Susan Collins, R-Maine, and Bob Casey, D-Pa., Sept. 11 introduced the SEPSIS Act, legislation which would task the Centers for…
Headline
The House Education and Workforce Committee advanced several bills Sept. 11, including legislation that would empower commercial insurance companies at the…
Headline
The Coalition to Strengthen America’s Healthcare Sept. 9 released a new advertisement, "Every Second Counts," which can be seen on television and digital…
Perspective
Congress returns to Washington, D.C., next week following the summer recess, and lawmakers can expect a busy fall as they face a full plate of issues that need…